Article
Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
The Journal of molecular diagnostics : JMD - 1 Sept 2018
Dupuy Aurélie, Lemonnier François, Fataccioli Virginie, Martin-Garcia Nadine, Robe Cyrielle, Pelletier Romain, Poullot Elsa, Moktefi Anissa, Mokhtari Karima, Rousselet Marie C, Traverse-Glehen Alexandra, Delarue Richard, Tournilhac Olivier, Delfau-Larue Marie H, Haioun Corinne, Ortonne Nicolas, Copie-Bergman Christiane, de Leval Laurence, Pujals Anaïs, Gaulard Philippe
Abstract excerpt
Angioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma associated with chemoresistance and a poor prognosis. Various nonsynonymous mutations in the R172 residue of IDH2 are present in 20% to 30% of AITL patients. In addition to their diagnostic value, these mutations are potentially targetable, especially by isocitrate dehydrogenase (IDH) 2 inhibitor, and therefore their identification in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
